ArticleJournal of primary care & community health
World Kidney Day 2025 in Gdańsk: Results and Insights From Community-Based Screening for Kidney Diseases and Their Risk Factors.
Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Renal Dose Adjustment in European Primary Care: Clinical Nuances and Practical Challenges.Journal of clinical medicine · 2026Article
- EPI-DRC Brasil: When public health campaigns become scientific evidence - a new paradigm for global nephrology.Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is often asymptomatic in early stages, making community screening initiatives crucial. This study describes a comprehensive awareness and screening initiative during World Kidney Day 2025 in Gdańsk, Poland. The objectives were to: (1) evaluate the feasibility and effectiveness of a collaborative community-based CKD screening and health education model, (2) determine the prevalence of decreased estimated Glomerular Filtration Rate (eGFR <60 mL/min/1.73 m²) using 3 different estimation equations, (3) analyze discrepancies between self-reported and objectively measured obesity as a CKD risk factor, (4) assess the usability of point-of-care creatinine testing device (Nova Max Pro Creatinine and eGFR Meter) in community screening settings, and (5) formulate recommendations for optimizing future community-based kidney health screening initiatives based on implementation experience.
methodsA collaborative event was organized by the Medical University of Gdańsk and the University of Gdańsk at a local shopping center. Trained volunteers administered CKD risk factor questionnaires, performed blood pressure measurements, and conducted capillary blood creatinine testing with on-site eGFR calculation using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equation. Participants received educational materials, urine test strips, and nutritional information. Data were subsequently reanalyzed using CKD-EPI 2021 and European Kidney Function Consortium (EKFC) equations.
results171 participants (67.3% women, median age 63 years) were screened. Self-reported risk factors included hypertension (38.6%), obesity (18.7%), nonsteroidal anti-inflammatory drugs (NSAIDs) use (16.4%), cardiovascular disease (15.8%), smoking (15.8%), family history of kidney disease (15.2%), and diabetes (11.1%). Decreased eGFR (<60 mL/min/1.73 m²) was identified in 4.1% (CKD-EPI 2009), 2.9% (CKD-EPI 2021), or 5.8% (EKFC) of participants. Among 86 participants with measured body mass index (BMI), 9.3% were unaware of their obesity despite BMI ≥30 kg/m². Furthermore, volunteers described the Nova Max Pro Creatinine and eGFR Meter as very easy to use. Recommendations for future community-based kidney health screening initiatives were formulated.
conclusionsCommunity-based CKD screening using a collaborative academic model is feasible and effective for combined early detection and health education initiatives. The substantial variation in detection rates between eGFR formulas necessitates careful equation selection, with CKD-EPI 2009 remaining optimal for European populations. Self-assessment proves unreliable for identifying obesity as a CKD risk factor, requiring objective measurements. Point-of-care creatinine testing demonstrates high usability for community settings. Future initiatives should prioritize demographic diversification, standardized anthropometric measurements, and multi-modal educational approaches to optimize early CKD detection and prevention efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.